Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Dasatinib/nilotinib/ponatinib

Pleural effusion, stroke and deep vein thrombosis: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gabriella M, et al. Practical management of side effects of tyrosine kinase inhibitor therapy in chronic myeloid leukemia. Orvosi Hetilap 62: 1198-1207, No. 30, 25 Jul 2021. Available from: URL: https://doi.org/10.1556/650.2021.32177 [Hungarian; summarised from a translation] Gabriella M, et al. Practical management of side effects of tyrosine kinase inhibitor therapy in chronic myeloid leukemia. Orvosi Hetilap 62: 1198-1207, No. 30, 25 Jul 2021. Available from: URL: https://​doi.​org/​10.​1556/​650.​2021.​32177 [Hungarian; summarised from a translation]
Metadaten
Titel
Dasatinib/nilotinib/ponatinib
Pleural effusion, stroke and deep vein thrombosis: 3 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41407-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Heparin/plasma

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Baricitinib

Case report

Imatinib

Case report

Nitroglycerin